Repligen
RGEN
#1868
Rank
HK$86.63 B
Marketcap
HK$1,364
Share price
6.13%
Change (1 day)
17.82%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of June 2026 : HK$23.15 Billion

According to Repligen 's latest financial reports the company's total assets are HK$23.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$22.95 B4.47%
2024-12-31HK$21.96 B-0.65%
2023-12-31HK$22.11 B11.79%
2022-12-31HK$19.78 B7.56%
2021-12-31HK$18.38 B24.66%
2020-12-31HK$14.75 B35.28%
2019-12-31HK$10.90 B79.76%
2018-12-31HK$6.06 B4.42%
2017-12-31HK$5.80 B159.29%
2016-12-31HK$2.24 B97.66%
2015-12-31HK$1.13 B13.9%
2014-12-31HK$0.99 B8.16%
2013-12-31HK$0.92 B22.35%
2012-12-31HK$0.75 B
2011-03-31HK$0.56 B1.38%
2010-03-31HK$0.55 B-2.96%
2009-03-31HK$0.57 B6.7%
2008-03-31HK$0.53 B135.8%
2007-03-31HK$0.22 B1.95%
2006-03-31HK$0.22 B3.54%
2005-03-31HK$0.21 B-6.66%
2004-03-31HK$0.23 B10.33%
2003-03-31HK$0.20 B-7.97%
2002-03-31HK$0.22 B-9.43%
2001-03-31HK$0.25 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.578 T 6,717.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$888.09 B 3,736.17%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$1.001 T 4,227.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$687.68 B 2,870.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.47 B-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$7.49 B-67.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$42.05 B 81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$20.29 B-12.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$91.99 B 297.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$59.10 B 155.31%๐Ÿ‡บ๐Ÿ‡ธ USA